COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0YQ9P
|
|||
Drug Name |
Amodiaquine
|
|||
Synonyms |
Amodiachin; Amodiachinum; Amodiaquin; Amodiaquina; Amodiaquinum; Basoquin; CQA; Camochin; Camoquin; Camoquinal; Camoquine; Flavoquin; Flavoquine; Miaquin; Sunoquine; Amodiaquine hydrochloride; Amodiaquine USP24; SN 10751; AMODIAQUINE, FLAVOQUINE; Amodiaquina [INN-Spanish]; Amodiaquinum [INN-Latin]; CAM-AQ 1; CAM-AQI; Cam-AQ1; Camoquin (TN); Flavoquine (TN); SN 10,751; WR-002977; Amodiaquine (USAN/INN); Amodiaquine [USAN:INN:BAN]; Amodiaquine, ring-closed; S. N. 10751
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) | Preclinical | [1] | Severe acute respiratory syndrome (SARS) | Preclinical | [1] |
Other Indication | Malaria | Withdrawn from market | [2] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H22ClN3O
|
|||
Canonical SMILES |
CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O
|
|||
InChI |
1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)
|
|||
InChIKey |
OVCDSSHSILBFBN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 86-42-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
9828, 77901, 598064, 4621370, 7886759, 7978694, 8151472, 10537079, 10589213, 11466337, 11467457, 11486233, 15374079, 17397079, 29221344, 46393825, 46506940, 47291303, 47440457, 47589170, 47810953, 47959956, 48415557, 49698430, 49956414, 50085969, 53789783, 53801183, 57321182, 76179602, 81062056, 81093107, 84974934, 92712423, 103190631, 103973209, 104299796, 105086070, 124596739, 124659480, 124801466, 124951249, 125358735, 126630109, 126678259, 128866127, 131333557, 134337988, 134970939, 135702891
|
|||
ChEBI ID |
CHEBI:2674
|
References | Top | |||
---|---|---|---|---|
1 | Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93. | |||
2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.